AR103277A1 - PROCESSES TO PREPARE ASK1 INHIBITORS - Google Patents

PROCESSES TO PREPARE ASK1 INHIBITORS

Info

Publication number
AR103277A1
AR103277A1 ARP150104290A ARP150104290A AR103277A1 AR 103277 A1 AR103277 A1 AR 103277A1 AR P150104290 A ARP150104290 A AR P150104290A AR P150104290 A ARP150104290 A AR P150104290A AR 103277 A1 AR103277 A1 AR 103277A1
Authority
AR
Argentina
Prior art keywords
compound
formula
salt
reaction conditions
under suitable
Prior art date
Application number
ARP150104290A
Other languages
Spanish (es)
Inventor
Wang Tao
S Thompson Andrew
Allen Siler David
Sarma Keshab
Evan Reynolds Troy
P Lathrop Stephen
V Heumann Lars
Griggs Nolan
Chiu Anna
J Burke Chan Brenda
Heath Brown Brandon
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AR103277A1 publication Critical patent/AR103277A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Exhibe actividad inhibitoria de la quinasa reguladora de señal de apoptosis (ASK1), y que por lo tanto es útil en el tratamiento de enfermedades tales como enfermedad renal, nefropatía diabética y fibrosis renal. La divulgación también provee compuestos que son intermediarios sintéticos. Reivindicación 1: Un método para preparar un compuesto de fórmula (1), caracterizado porque comprende los siguientes pasos: (a) carboxilar un compuesto de fórmula (5) o una sal del mismo, bajo condiciones de reacción adecuadas para formar un compuesto de fórmula (4) o un hidrato, solvato, o una sal del mismo; (b) clorar un compuesto de fórmula (4) o un hidrato, solvato o sal del mismo bajo condiciones de reacción adecuadas para formar un compuesto de fórmula (2) o sal del mismo; y (c) poner en contacto un compuesto de fórmula (2) o sal del mismo con un compuesto de fórmula (3) o sal del mismo, bajo condiciones de reacción adecuadas para dar un compuesto de fórmula (1).It exhibits inhibitory activity of apoptosis signal regulatory kinase (ASK1), and which is therefore useful in the treatment of diseases such as kidney disease, diabetic nephropathy and renal fibrosis. The disclosure also provides compounds that are synthetic intermediates. Claim 1: A method for preparing a compound of formula (1), characterized in that it comprises the following steps: (a) carboxylating a compound of formula (5) or a salt thereof, under suitable reaction conditions to form a compound of formula (4) or a hydrate, solvate, or salt thereof; (b) chlorinating a compound of formula (4) or a hydrate, solvate or salt thereof under suitable reaction conditions to form a compound of formula (2) or salt thereof; and (c) contacting a compound of formula (2) or salt thereof with a compound of formula (3) or salt thereof, under suitable reaction conditions to give a compound of formula (1).

ARP150104290A 2014-12-23 2015-12-23 PROCESSES TO PREPARE ASK1 INHIBITORS AR103277A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462096391P 2014-12-23 2014-12-23

Publications (1)

Publication Number Publication Date
AR103277A1 true AR103277A1 (en) 2017-04-26

Family

ID=58700141

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150104290A AR103277A1 (en) 2014-12-23 2015-12-23 PROCESSES TO PREPARE ASK1 INHIBITORS

Country Status (1)

Country Link
AR (1) AR103277A1 (en)

Similar Documents

Publication Publication Date Title
MX2017008417A (en) Processes for preparing ask1 inhibitors.
CO2017012267A2 (en) Naphthyridine compounds as inhibitors of jak kinase
CU20160188A7 (en) INDAZOLE COMPOUNDS SUBSTITUTED AS IRAK4 INHIBITORS
EA201890308A1 (en) SUBSTITUTED ASO COMPOUNDS AS IRAK-4 INHIBITORS
EA201890307A1 (en) INDASOLIC AND AZAINDASOLIC COMPOUNDS AS IRAK-4 INHIBITORS
MY188447A (en) Indazole compounds as fger kinase inhibitor, preparation and use thereof
MX2020001278A (en) Synthesis of polycyclic-carbamoylpyridone compounds.
SV2017005434A (en) 2-AMINO-3,5-DIFLUORO-6-METHYL-6-PHENYL-3,4,5,6-TETRAHYDROPIRIDINS IN QUALITY OF BACE1 INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EA202092609A1 (en) ANTIBODIES TO CD38 FOR TREATMENT OF ACUTE MYELOLEUKOSIS
NZ726356A (en) Processes for preparing antiviral compounds
SV2017005433A (en) SYNTHESIS OF COPANLISIB AND ITS DICLORHYDRATE SALT
MY197440A (en) Heteroamatic compounds as btk inhibitors
ZA201607838B (en) Methods for biological production of very long carbon chain compounds
EA201790400A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
EA201790982A1 (en) SYNTHESIS OF KOPANLISIB AND ITS DIHYDROCHLORIDE
MX2016010973A (en) Aminocarbonylcarbamate compounds.
CU20160195A7 (en) QUINOLIZINONE DERIVATIVES AS PI3K INHIBITORS
IL248258B (en) Analogs of 4h-pyrazolo[1,5-a]benzimidazole compounds as parp inhibitors
IL278017A (en) Process for the cyclopropanation of olefins using n-methyl-n-nitroso compounds
EA201691999A1 (en) NEW SULPHONYLAMINOBENZAMIDE COMPOUNDS
DOP2019000021A (en) DERIVED FROM USEFUL TRIAZOLOPIRAZINONE AS A HUMAN PDE1 INHIBITOR
AR103277A1 (en) PROCESSES TO PREPARE ASK1 INHIBITORS
BR112017012716A2 (en) process for preparing a compound, and method for making a compound.
UA112146C2 (en) METHOD OF OBTAINING 4,1-BENZOXATIEPIN-3-ON
IN2014MU00566A (en)

Legal Events

Date Code Title Description
FB Suspension of granting procedure